Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Trial Overview
Trial Team
Essential Trial Documentation
Media and press coverage
Title
NHS Cancer Vaccine Launch Pad (CVLP)
Description
CVLP is a project to establish the feasibility of pathways to enable NHS patients with cancer to access cancer vaccine and immunotherapy trials. The study is investigating the optimum process for patients, across multiple cancer types, to receive personalised cancer vaccines and novel immunotherapies by enrolment in the CVLP.
Objectives
Primary:
- To determine whether it is feasible to recruit cancer patients to a platform for cancer vaccine and immunotherapy trials, whether there is capacity for tissue samples to be prepared within a suitable time frame (where required) and if this results in acceptable participation in cancer vaccine and immunotherapy clinical trials.
Trial Design
The CVLP is a multicentre prospective observational cohort study for the recruitment and referral of NHS cancer patients to clinical trials of cancer vaccines and immunotherapies available through the CVLP.
Trial Status
Open to recruitment
For more information on the CVLP, inlcluding supported vaccine and immunotherapy trials and participating NHS Trusts, please follow the link below:
NHS Cancer Vaccine Launch Pad (CVLP) I Southampton Clincical Trials Unit I University of Southampton
Population
NHS patients with early or late-stage cancer who are receiving cancer treatment on the NHS will be screened using an eligibility criteria and, where required, have tissue (and sometimes blood) samples sent to the laboratories for analysis. Depending on mutations present in the samples, patients may be eligible for referral for one of the vaccine or immunotherapy trials.
Funder
CVLP is funded by NHS England.
Watch a video on the NHSE Cancer Vaccine Launch Pad
Senior Trial Manager
Nicole Keyworth
Trial Managers:
Sam Goode, Laura Pope and Tiffany Joyce
Clinical Research Fellow:
Dr Jessica Curtis
Trial Coordinator:
Josh Shephard
Data Manager:
Charlotte Stuart
Clinical Data Coordinator:
Masood Nazari
Contact information for trial queries
Email: cvlp@soton.ac.uk
Phone: 023 8120 5154
CVLP Documents
NHSE CVLP protocol v4 30-Jul-2025
NHSE CVLP Participant Infromation Sheet v11 29-Jul-2025
NHSE CVLP Summary Participant Information Sheet v3 29-Jul-2025
NHSE CVLP Informed Consent Form v9 29-Jul-2025
NHSE CVLP GP Letter v3 17-Jul-2025
BNT113-01 – Head and Neck Cancer
CVLP-BNT113-01 Referral Form (Main Trial Screening) v1 15-Apr-2025
CVLP-BNT113-01 Referral Form (Pre-screening) v2 17-Oct-2025
Technical Requirements for CVLP Sites - BNT113-01 - v2 10-Oct-2025
ROSETTA Lung
CVLP - ROSETTA Lung-02 Referral Form v1 01-Dec-2025
CVLP - ROSETTA Lung-02 Sample Shipment Form v2 05-Dec-2025
Technical Requirements for CVLP Sites - ROSETTA Lung-02 v1 13-Nov-2025
Press releases, video clips and other external websites
(University of Southampton cannot accept responsibility for external websites)
CVLP explainer video
CVLP patient story - Aug 2024
BBC Inside Health presenter James Gallagher meets Steve, one of the first patients to recieve a cancer vaccine through the NHS Cancer Vaccine Launch Pad, and discusses the technology behind personalised cancer vaccines.
CVLP launch, May 2024
BBC South Today report by Sean Killick, 31.05.24
Professor Gareth Griffiths, Director of the Southampton Clinical Trials Unit, talks about the Cancer Vaccine Launch Pad.
Ali Richards, who was a participant in a previous cancer vaccine trial, explains why she is supporting the CVLP programme and hopes it can mean more cancer patients get access to trials of new personalised cancer vaccines.